470
Views
5
CrossRef citations to date
0
Altmetric
Research Articles

Discovery of small molecule inhibitors of chikungunya virus proteins (nsP2 and E1) using in silico approaches

, , &
Pages 1373-1385 | Received 06 Jan 2020, Accepted 10 Feb 2020, Published online: 05 Mar 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Meenakshi Chaudhary & Deepak Sehgal. (2022) In silico identification of natural antiviral compounds as a potential inhibitor of chikungunya virus non-structural protein 3 macrodomain. Journal of Biomolecular Structure and Dynamics 40:22, pages 11560-11570.
Read now

Articles from other publishers (4)

Saikat De, Soumyajit Ghosh, Supriya Suman Keshry, Chandan Mahish, Chinmayee Mohapatra, Ankeeta Guru, Prabhudutta Mamidi, Ankita Datey, Sweta Smita Pani, Dileep Vasudevan, Tushar Kant Beuria, Subhasis Chattopadhyay, Bharat Bhusan Subudhi & Soma Chattopadhyay. (2022) MBZM-N-IBT, a Novel Small Molecule, Restricts Chikungunya Virus Infection by Targeting nsP2 Protease Activity In Vitro , In Vivo , and Ex Vivo . Antimicrobial Agents and Chemotherapy 66:7.
Crossref
RAHAT ALI, AFTAB ALAM, SATYENDRA K. RAJPUT & RAZI AHMAD. (2022) Pharmacotherapeutics and molecular docking studies of alpha-synuclein modulators as promising therapeutics for Parkinson’s disease. BIOCELL 46:12, pages 2681-2694.
Crossref
Verena Battisti, Ernst Urban & Thierry Langer. (2021) Antivirals against the Chikungunya Virus. Viruses 13:7, pages 1307.
Crossref
Md. Mukthar Mia, Mahamudul Hasan, Md. Abir Hasan, Mohammad Abdus Shahid Hossain, Md. Mazharul Islam & Md. Sawkat Hasan Saraf. (2021) Discovery of mushroom-derived bioactive compound's draggability against nsP3 macro domain, nsP2 protease and envelope glycoprotein of Chikungunya virus: An in silico approach. Informatics in Medicine Unlocked 26, pages 100753.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.